Literature DB >> 155804

Thymic deficiency in Down's syndrome.

S Levin, M Schlesinger, Z Handzel, T Hahn, Y Altman, B Czernobilsky, J Boss.   

Abstract

Children with Down's syndrome (DS) often have small and abnormal thymuses, with lymphocyte depletion, diminution of the cortex, and loss of corticomedullary demarcation--a picture resembling thymic involution. Besides this, they have markedly enlarged Hassall's corpuscles, some surrounded by a sheath of lymphocytes. Patients with DS are known to have increased numbers of respiratory infections; they also have a higher incidence of lymphatic leukemia than do individuals who do not have DS. Studies of cell-mediated (thymic-dependent) immunity demonstrate that children with DS have both diminished numbers of T cells as well as functional deficiency of these cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 155804

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  30 in total

1.  The expression of CD18 is increased on Trisomy 21 (Down syndrome) lymphoblastoid cells.

Authors:  G M Taylor; A Williams; S W D'Souza; W D Fergusson; D Donnai; J Fennell; R Harris
Journal:  Clin Exp Immunol       Date:  1988-02       Impact factor: 4.330

2.  Interferon deficiency syndrome.

Authors:  S Levin; T Hahn
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

3.  Cell-mediated cytotoxicity in Down syndrome: impairment of allogeneic mixed lymphocyte reaction, NK and NK-like activities.

Authors:  D Montagna; R Maccario; A G Ugazio; L Nespoli; E Pedroni; P Faggiano; G R Burgio
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

4.  Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells.

Authors:  R Maccario; A G Ugazio; L Nespoli; C Alberini; D Montagna; F Porta; F Bonetti; G R Burgio
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

5.  Monoclonal antibody defined T cell subsets and autologous mixed lymphocyte reaction in Down's syndrome.

Authors:  S Gupta; S M Fikrig; E Mariano; Q Quazi
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

6.  Antibody response to pneumococcal vaccine in patients with trisomy-21 (Down's syndrome).

Authors:  T Nurmi; M Leinonen; V M Häivä; A Tiilikainen; K Kouvalainen
Journal:  Clin Exp Immunol       Date:  1982-05       Impact factor: 4.330

Review 7.  The association between immunodeficiency and congenital heart disease.

Authors:  D J Radford; Y H Thong
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

8.  Cell-mediated immunodeficiency in Down's syndrome: normal IL-2 production but inverted ratio of T cell subsets.

Authors:  R Karttunen; T Nurmi; J Ilonen; H M Surcel
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

9.  Altered expression of autoimmune regulator in infant down syndrome thymus, a possible contributor to an autoimmune phenotype.

Authors:  Gabriel Skogberg; Vanja Lundberg; Susanne Lindgren; Judith Gudmundsdottir; Kerstin Sandström; Olle Kämpe; Göran Annerén; Jan Gustafsson; Jan Sunnegårdh; Sjoerd van der Post; Esbjörn Telemo; Martin Berglund; Olov Ekwall
Journal:  J Immunol       Date:  2014-07-18       Impact factor: 5.422

10.  Natural killer cell function in trisomy-21 (Down's syndrome).

Authors:  T Nurmi; K Huttunen; O Lassila; M Henttonen; A Säkkinen; S L Linna; A Tiilikainen
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.